Appuyez sur | HIPRA

who we are

Appuyez sur

26/06/2024 - 15:09

Significant advancements and a fifteen-month extension for the RBDCOV Project

Humain

18/10/2023 - 16:14

BIMERVAX® becomes the first COVID-19 vaccine approved by WHO

Humain

17/07/2023 - 14:43

AEMPS authorizes the clinical trial to study the joint vaccination of HIPRA's COVID-19 vaccine with an influenza vaccine

Humain

29/05/2023 - 08:15

AEMPS authorizes the clinical trial to study HIPRA's COVID-19 vaccine in adolescents between 12 and 17 years old

Humain

11/04/2023 - 16:57

The Spanish Prime Minister defines HIPRA’s vaccine as a 'historic milestone' that reinforces the country's leadership in the European health sector

Humain

31/03/2023 - 14:27

BIMERVAX® has also obtained the approval of the European Commission to be marketed

Humain